Acupuncture and medicine of artificial cycle therapy in polycystic ovary syndrome: a randomized controlled trial
- Conditions
- polycystic ovary syndrome
- Registration Number
- ITMCTR2100004559
- Lead Sponsor
- The First Hospital of Lanzhou University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
(1) Women between the ages of 18 and 35.
(2) Those who meet the diagnostic criteria of PCOS.
(3) Fallopian tube patency test, including hysterosalpingography and diagnostic laparoscopy, showed that at least one side of fallopian tube was patency.
(4) Sperm concentration and total motility (including fast forward movement and non-fast forward movement) in husband's semen analysis.
(5) Women who know that they may receive comfort acupuncture or placebo and can receive research.
(6) With the approval of the hospital ethics committee, sign the informed consent form.
(1) Aged under 18 or over 35 years.
(2) Oral administration of drugs affecting test results in the last 3 months, such as contraceptives or other hormone drugs, insulin sensitizers, Lipid-lowering drugs.
(3) The patient has other androgen excess related diseases (including congenital adrenal hyperplasia and secretion of 21 hydroxylase deficiency). Androgen tumors, excessive use of androgen-producing drugs, Cushing's syndrome, severe insulin resistance, thyroid function disorders and hyperprolactinemia).
(4) Patients with organic diseases in important organs such as heart, liver, lung and kidney, or patients with mental disorders and other reasons who cannot cooperate with the test.
(5) Acupuncture has been used to treat this disease in the last 6 months.
(6) There are birth requirements within 4 months.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pregnancy rate;
- Secondary Outcome Measures
Name Time Method Body mass index;rosenfield global ance grade system;Serum neutral hormone;ultrasonic examination;modified Ferryman-Gallwey scale;